Matthias Tschöp
Helmholtz Munich/Matthias Tunger
Helmholtz Munich/Matthias Tunger

Helmholtz Zentrum Munich

Matthias Tschöp

2024 Jury | Life Sciences 2023 2023 Speaker | Breakthrough Day Life Sciences Jury

Matthias Tschöp is the CEO of Helmholtz Munich, VP of the Helmholtz Association and AvH Professor at the TU of Munich. He unraveled fundamental gut-brain signals to discover the first highly effective drugs for human obesity in collaboration with the chemist Richard DiMarchi – the dual and triple gut hormone multi-agonists. A first representative is FDA-approved. Tschöp has received numerous awards, including the Banting Medal, the Heinrich Wieland Prize and the Ernst Schering Prize. He holds an adjunct professorship at Yale University and an honorary doctorate at Leipzig University. He was elected a member of the German, Bavarian, and European Academies of Sciences, the ASCI and the AAP.

Content by this speaker

Explore more content of Falling Walls

Events with Matthias Tschöp

Thu | Nov 09, 2023 | 02.00 PM - 02.15 PM Berlin Time

Matthias Tschöp: Breaking the Wall of Obesity

Further Activities to have a look at